Protalix BioTherapeutics (PLX) Current Taxes (2023 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Current Taxes of $3.2 million for Q1 2026, down 7.85% year-over-year from $3.5 million in Q1 2025, and up 8.58% quarter-over-quarter from $2.9 million in Q4 2025.
Protalix BioTherapeutics (PLX) Current Taxes (2023 - 2026) Analysis & Trends
Protalix BioTherapeutics' Current Taxes history runs 4 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Current Taxes fell 7.85% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 7.85% YoY), while the FY2025 annual figure was $2.9 million, down 15.13% from the prior year.
- Current Taxes for Q1 2026 stood at $3.2 million, up from $2.9 million in the prior quarter.
- The five-year high for Current Taxes was $3.7 million in Q2 2025, with the low at $2.4 million in Q3 2025.
- The 4-year median for Current Taxes is $3.2 million (2026), against an average of $3.2 million.
- The sharpest annual moves came in 2024 and 2025: Current Taxes increased 20.86% in 2024, then dropped 15.13% in 2025.
- Protalix BioTherapeutics' Current Taxes stood at $2.9 million in 2023, then climbed by 20.86% to $3.5 million in 2024, then retreated by 15.13% to $2.9 million in 2025, then advanced by 8.58% to $3.2 million in 2026.
- Business Quant data shows PLX's Current Taxes at $3.2 million in Q1 2026, $2.9 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.36 Mn |
| 10 | Protalix BioTherapeutics | 190.37 Mn | 149.71 Mn | 12.13 Mn | 4.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.22 Mn |
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 2.95 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Dec 31, 2023 | 2.88 Mn |